Everolimus and Gemfibrozil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Everolimus (everolimus) and Gemfibrozil (gemfibrozil). Common drug interactions include abdominal pain among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Everolimus and Gemfibrozil. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Everolimus?

Everolimus has active ingredients of everolimus. eHealthMe is studying from 16,228 Everolimus users. Check the latest studies of Everolimus.

What is Gemfibrozil?

Gemfibrozil has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 18,213 Gemfibrozil users. Check the latest studies of Gemfibrozil.

On Jul, 04, 2026

24 people who take Everolimus and Gemfibrozil together, and have interactions are studied.

Everolimus and Gemfibrozil drug interactions.

What are the common drug interactions of Everolimus and Gemfibrozil, by gender? *:

female:

Abdominal pain
Abdominal pain upper
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Hyperglycaemia (high blood sugar)
Nausea (feeling of having an urge to vomit)
Pancreatitis acute (sudden inflammation of pancreas)
Pneumonia
Cough
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Liver disorder (liver diseases)

male:

Diarrhoea
Cholecystitis acute (rapid infection of gallbladder)
Delirium (wild excitement)
Dry skin
Skin exfoliation (removal of the oldest dead skin cells)
Skin haemorrhage (bleeding into skin)
Skin ulcer
Abdominal pain
Back pain
Epinephrine decreased

What are the common drug interactions of Everolimus and Gemfibrozil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Gastrointestinal disorder (functional problems of gastrointestinal tract)
Liver disorder (liver diseases)
Type 2 diabetes mellitus

40-49:

Abdominal pain
Abdominal pain upper
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Hyperglycaemia (high blood sugar)
Nausea (feeling of having an urge to vomit)
Pancreatitis acute (sudden inflammation of pancreas)

50-59:

Blood creatinine increased
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Febrile neutropenia (fever with reduced white blood cells)
Infection
Renal failure (kidney dysfunction)
Sepsis (a severe blood infection that can lead to organ failure and death)
Pneumonia
Cough

60+:

Cholecystitis acute (rapid infection of gallbladder)
General physical health deterioration (weak health status)
Back pain
Epinephrine decreased
Fatigue (feeling of tiredness)
Groin pain
Memory impairment
Muscular weakness (muscle weakness)
Pelvic pain
Asthenia (weakness)

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 8 people, 33.33%
Pain: 7 people, 29.17%
Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 25.00%
Immunodeficiency Disorders: 6 people, 25.00%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 5 people, 20.83%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 20.83%
Dyslipidaemia (abnormal amount of lipids): 5 people, 20.83%
Insomnia (sleeplessness): 5 people, 20.83%
Muscle Aches (muscle pain): 5 people, 20.83%
Oedema (fluid collection in tissue): 5 people, 20.83%

* Approximation only. Some reports may have incomplete information.

Do you take Everolimus and Gemfibrozil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously